|  IDAHO                                              |  82-0266517                    |
|---------------------------------------------------------------|-------------------------------------|
| (State or other jurisdiction ofincorporation or organization) | (I.R.S. EmployerIdentification No.) |

----

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PART I. CONSOLIDATED FINANCIAL INFORMATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Financial Statements. (Unaudited) |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |      Consolidated Balance Sheets |  3 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |      Consolidated Statements of Operations  |  4 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |      Consolidated Statements of Cash Flows |  5 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |      Notes to Condensed Consolidated Financial Statements |  6 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Management's Discussion and Analysis of Financial Condition and Plan of Operations |  12 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Quantitative and Qualitative Disclosures About Market Risk |  16 |
| Item 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Controls and Procedures |  16 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |   |
| PART II. OTHERINFORMATION                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |  19 |
| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Legal Proceedings |   |
| Item 1A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Risk Factors |  19 |
| Item 2.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Unregistered Sales of Equity Securities and Use of Proceeds |  19 |
| Item 3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | DefaultsUpon Senior Securities |  19 |
| Item 4.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | (Removed) |  19 |
| Item 5.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Other Information |  19 |
| Item 6.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | Exhibits |  19 |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |   |   |
| Signatures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |  20 |

----

| PART I. | CONSOLIDATED FINANCIAL INFORMATION |
|---------|------------------------------------|

| Item 1.   | Financial Statements. |
|---------------------|-----------------------|

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                                      |
|--------------------------------------------------------------------------------------------------------------------------------------|
| CONSOLIDATED  BALANCE SHEETS                                                                                               |
|                                                                                                                                 |   |   |   |   |
|                                                                                                                                 |   |   |   |   |
|                                                                                                                                 |   | June 30, |   | December 31, |
|                                                                                                                                 |   | 2011 |   | 2010 |
| ASSETS                                                                                                                               |   |     (Unaudited) |   |   |
|                                                                                                                                 |   |   |   |   |
| CURRENT ASSETS:                                                                                                                      |   |   |   |   |
|       Cash and cash equivalents                                                                        |   |  $         153,315 |   |  $      442,812 |
|       Accounts receivable                                                                              |   |            607,500 |   |          277,636 |
|       Inventory                                                                                        |   |            468,228 |   |          206,563 |
|                                                                                                                                 |   |   |   |   |
|         Total current assets                                                                 |   |          1,229,043 |   |          927,011 |
|                                                                                                                                 |   |   |   |   |
|  FIXED ASSETS, NET                                                                                                              |   | 147,020 |   | 158,329 |
|                                                                                                                                 |   |   |   |   |
|  OTHER ASSETS                                                                                                                   |   | 13,695 |   | 13,695 |
|                                                                                                                                 |   |   |   |   |
|     Total assets                                                                                                 |   |  $      1,389,758 |   |  $   1,099,035 |
|                                                                                                                                 |   |   |   |   |
|                                                                                                                                 |   |   |   |   |
|  LIABILITIES AND SHAREHOLDERS' EQUITY                                                                                           |   |   |   |   |
|                                                                                                                                 |   |   |   |   |
|  CURRENT LIABILITIES:                                                                                                           |   |   |   |   |
|        Accounts payable and accrued expenses                                                      |   |  $         787,290 |   |  $      423,083 |
|        Customer deposits                                                                          |   |            270,610 |   |          564,000 |
|        Current portion of note payable                                                            |   | 41,476 |   | 30,836 |
|                                                                                                                                 |   |   |   |   |
|         Total current liabilities                                                            |   |          1,099,376 |   |       1,017,919 |
|                                                                                                                                 |   |   |   |   |
|                                                                                                                                 |   |   |   |   |
|    LONG TERM NOTE PAYABLE                                                                                             |   | 10,930 |   | 41,028 |
|                                                                                                                                 |   |   |   |   |
|         Total liabilities                                                                    |   |          1,110,306 |   |       1,058,947 |
|                                                                                                                                 |   |   |   |   |
|  COMMITMENTS AND CONTINGENCIES                                                                                                  |   |   |   |   |
|                                                                                                                                 |   |   |   |   |
|  SHAREHOLDERS' EQUITY:                                                                                                          |   |   |   |   |
|  Common stock, $.001 par value, 42,750,000 shares authorized;                                                                   |   |   |
|       31,590,497 shared issued and outstanding as of June 30, 2011 and December 31, 2010, respectively | 31,591 |   | 31,591 |
|  Additional paid-in capital                                                                                                     |   | 13,479,038 |   | 13,479,038 |
|   Deferred compensation                                                                                                         |   | (568,909) |   | (764,805) |
|   Accumulated deficit                                                                                                           |   | (12,662,268) |   | (12,705,736) |
|                                                                                                                                 |   |   |   |   |
|         Total shareholders' equity                                                           |   |            279,452 |   |            40,088 |
|                                                                                                                                 |   |   |   |   |
|  Total liabilities and shareholders' equity                                                                                     |   |  $      1,389,758 |   |  $   1,099,035 |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                                           |                                                                                              |   |
|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|--------|
|  CONSOLIDATED STATEMENTS OF OPERATIONS                                                                               |                                                                                              |   |
|    (Unaudited)                                                                                                  |                                                                                              |   |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|                                                                                                                      | Three Months Ended June 30,                                                                       |   |   Six Months Ended June 30, |
|                                                                                                                      | 2011                                                                                              |   | 2010 |   | 2011 |   | 2010 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Revenues                                                                                                                  |  $         699,415                              |   |  $           77,401 |   |  $   1,423,270 |   |  $     116,401 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Cost of goods sold                                                                                                        |             239,123                   |   |               17,048 |   |             484,970 |   |               17,048 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Gross profit                                                                                                              |             460,292                   |   |               60,353 |   |             938,300 |   |               99,353 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Costs and expenses:                                                                                                       |                                                                                              |   |   |   |   |   |   |
|       General and administrative                                                            |             249,531                   |   |             215,688 |   |             498,131 |   |             325,124 |
|        Stock based compensation                                                             |               97,948        |   |             229,966 |   |             195,896 |   |             243,299 |
|       Research and development                                                              |               81,924        |   |             244,756 |   |             197,433 |   |             355,744 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|                  Total costs and expenses |             429,403                   |   |             690,410 |   |              891,490 |   |             924,167 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Income (Loss) from operations                                                                                             |               30,889        |   |            (630,057) |   |               46,840 |   |             (824,814) |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Other expenses:                                                                                                      |                                                                                              |   |   |   |   |   |   |
|        Interest expense                                                                     |               (1,912)       |   |               (2,052) |   |               (3,372) |   |                (4,287) |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|               Total other expense                   |               (1,912)       |   |               (2,052) |   |               (3,372) |   |               (4,287) |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Net Income (Loss)                                                                                                         |  $          28,977                         |   |  $        (632,109) |   |                $   43,468 |   |            $    (829,101) |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Weighted average number of common shares                                                                                  |                                                                                              |   |   |   |   |
|    outstanding-basic and diluted                                                                           | 27,201,762                                                                                        |   |         26,533,104 |   | 27,201,762 |   |         26,023,325 |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
| Loss per common share - basic and diluted                                                        |   $                (*) |   |  $             (0.02) |   | $           * |   | $         (0.03) |
|                                                                                                                      |                                                                                              |   |   |   |   |   |   |
|   * Less than $0.01, per share                                                                                  |                                                                                              |   |   |   |   |   |   |

----

| ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY                                                       |
|-------------------------------------------------------------------------------------------------------|
| CONSOLIDATED STATEMENTS OF CASH FLOWS                                                                 |
|      (Unaudited)                                                                  |
|                                                                                                  |   |   |   |   |
|                                                                                                  |   |   |   |   |
|                                                                                                  |   | Six Months Ended June 30, |
|                                                                                                  |   | 2011 |   | 2010 |
|                                                                                                  |   |   |   |   |
| Cash Flows From Operating Activities:                                                                 |   |   |   |   |
| Net Income (loss)                                                                                     |   |   $           43,468 |   |  $      (829,101) |
| Adjustments to reconcile net income (loss) to net                                                     |   |   |   |   |
|   cash used by operating activities:                                                             |   |   |   |   |
|       Depreciation                                                      |   |                11,309 |   |              11,324 |
|        Stock-based compensation                                    |   |               195,896 |   |               256,632 |
| Changes in assets and liabilities:                                                                    |   |   |   |   |
|       Accounts receivable                                                    |   |            (329,864) |   |            (19,500) |
|       Inventory                                                              |   |            (261,665) |   |            (12,648) |
|       Accounts payable and accrued expenses                                  |   |                70,817 |   |            278,527 |
|                                                                                                  |   |   |   |   |
|       Net cash used in operating activities                                  |   |            (270,039) |   |          (314,766) |
|                                                                                                  |   |   |   |   |
| Cash Flows From Financing Activities:                                                                 |   |   |   |   |
|       Repayments toward notes payable                                        |   |              (19,458) |   |            (17,878) |
|       Proceeds from sales of common stock                                    |   |                       - |   |            419,000 |
|                                                                                                  |   |   |   |   |
|       Net cash (used in ) provided by financing activities                   |   |              (19,458) |   |            401,122 |
|                                                                                                  |   |   |   |   |
|          Net increase (decrease) in cash and cash equivalents |   |            (289,497) |   |              86,356 |
|                                                                                                  |   |   |   |   |
|          Cash and cash equivalents, beginning of period       |   |              442,812 |   |              59,110 |
|                                                                                                  |   |   |   |   |
|          Cash and cash equivalents, end of period        |   |  $          153,315 |   |  $        145,466 |
|                                                                                                  |   |   |   |   |
| Supplemental Disclosures                                                                              |   |   |   |   |
|                                                                                                  |   |   |   |   |
|          Cash paid during the year for interest               |   |  $              3,371 |   |  $            4,293 |
|                                                                                                  |   |   |   |   |
|          Non-cash investing and financing activities:    |   |   |   |   |
|                                                                                                  |   |   |   |   |
|          Common stock issued for conversion of           |   |   |   |   |
|               accrued salary    |   |  $                     - |   |  $     1,739,000 |
|                                                                                                  |   |   |   |   |

----

----

----

|      Warrants  |  2,024,982             |   |   |
|----------------------------------------------|-----------------------------|--------|--------|
|     Stock options        |    9,250,000 |   |   |
|                                         |  11,274,982            |   |   |

----

----

|     January 31, 2012 |  2,700,000 |   |   |
|-----------------------------------------------|-----------------|--------|--------|
|     January 31, 2013 |  1,800,000 |   |   |
|     January 31, 2015 |  900,000   |   |   |

|                                                 |   |  Three Months |   |   Six Months |   |
|------------------------------------------------------|--------|--------------------|--------|------------------------|--------|
|     As originally reported  |   |  ($566,810)   |   |  ($763,802)       |   |
|     Adjustment              |   |  (65,299)     |   |   (65,299)   |   |
|     As restated             |   |  ($632,109)   |   |  ($829,101)       |   |

|     As originally reported  |   |   |   |  ($1,687,814)   |   |
|------------------------------------------------------|--------|--------|--------|----------------------|--------|
|     Adjustment              |   |   |   |   (90,195) |   |
|     As restated             |   |   |   |  ($1,778,009)   |   |

----

----

| Item 2.   | Management's Discussion and Analysis of Financial Condition and Results of Operations |
|---------------------|---------------------------------------------------------------------------------------|

----

----

----

----

| Item 3.   | Quantitative and Qualitative Disclosures About Market Risk |
|---------------------|------------------------------------------------------------|

| Item 4.   | Controls and Procedures |
|---------------------|-------------------------|

----

----

----

| Item 1.   | Legal Proceedings |
|---------------------|-------------------|

| Item 1A.   | Risk Factors |
|----------------------|--------------|

| Item 2.   | Unregistered Sales of Equity Securities and Use of Proceeds |
|---------------------|-------------------------------------------------------------|

| Item 3.   | Defaults Upon Senior Securities |
|---------------------|---------------------------------|

| Item 4.   | (Removed) |
|---------------------|-----------|

| Item 5.   | OtherInformation |
|---------------------|------------------|

| Item 6.   | Exhibits |
|---------------------|----------|

| 31.1    | Form 302 Certification of Chief Executive Officer                                 |
|---------|-----------------------------------------------------------------------------------|
| 31.2    | Form 302 Certification of Principal Financial Officer                             |
| 32.1    | Form 906 Certification of Chief Executive Officer and Principal Financial Officer |
| 101.INS | XBRL Instance Document                                                            |
| 101.SCH | XBRL Taxonomy Extension Schema Document                                           |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document                             |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document                              |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document                                   |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document                            |

----

----